The association of previous cancer history with the incidence of prostate cancer harboring germline mutations. Comparing NCCN-based risk groups to the PROTEUS definition of high-risk localized ...
There is ongoing clinical need to improve estimates of disease outcome in prostate cancer. Machine learning (ML) approaches to pathologic diagnosis and prognosis are a promising and increasingly used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback